French digital minister tells Big Tech platforms to scale up “fact-checking capabilities”

Telecom ministers from European countries have asked the major online platforms to ensure they have the adequate capacity to handle “misinformation” in Central and Eastern Europe, which they say are the major targets of Russian propaganda.

On March 8, officials from EU governments and representatives from the major online platforms met in France to discuss how to fight disinformation being spread by the Russian government. Initially, the agenda of the informal meeting was the Metaverse, how to bring more women to the technology sector, and environment. The agenda was changed in light of the Russian invasion of Ukraine.

In a joint statement, the ministers said: “The battles initiated by Russia in the current conflict are raging not only on the ground but also on the internet.”

France’s digital minister Cédric O said that online platforms had made some efforts to fight Russian propaganda, adding that the accounts of Russian state-controlled media outlets Sputnik and RT have been removed on the major platforms. However, O said it was important to put “pressure on the platforms to do even more.”

During the meeting, the ministers made two requests, according to a report by EURACTIV. They asked the platforms to respond to take down requests from governments more quickly. And, they asked them to increase their content moderation teams in the languages spoken in Central and Eastern Europe.

Keep reading

‘Fact-Checkers’ Are Technocracy’s Digital Brownshirts

We are under siege. A nihilistic fanaticism is running free among us thanks to the emergence of a journalistic “ethos” that establishes an almost complete equivalence between the “truth” and those utterances that support the strategic goals of the great economic and digital powers of our time.

A few months ago Facebook censored an article in the British Medical Journal that highlighted serious irregularities in Pfizer’s clinical vaccine trials. Then two weeks ago, fact-checkers from the Spanish websites Newtral and Maldita burst into the public square to accuse professor of Pharmacology, renowned expert in drug safety, and ex-WHO adviser, Joan Ramón Laporte of foisting lies and disinformation onto the Spanish populace. This, in reaction to Laporte’s testimony before a Spanish parliamentary commission investigating the country’s vaccination effort.

Despite his towering credentials, his intervention was quickly tarred as problematic by the media and subsequently banned by YouTube. The crime of this new Galileo Galilei? Alerting the assembled parliamentarians to the existence of grave procedural irregularities in the trials for the vaccines, and questioning the wisdom of a health strategy that aims to inject every Spanish child over the age of six with a new, poorly tested, and largely ineffective medication.

This incident reveals that the fact-checkers will attack anyone who does not accept the truth as dictated by the great economic and government centers of the world. This is not the usual official media obfuscation to which we’ve become accustomed over the years, but rather a brazen McCarthyist intimidation device, designed to frighten citizens into submission by appealing to their lowest and most ignoble instincts, an approach lain bare in Maldita’s smug and Manichaean slogan: “Join and support us in our battle against lies.”

Under this harsh binary logic, an internationally famous scientist like Laporte is not even given the opportunity to be judged wrong or misguided in good faith. Rather, he is immediately accused of being a willful and dangerous liar who must be immediately banished from public view.

Keep reading

COVID “Conspiracy Theories” Have Now Magically Become “Fact-Checked” Mainstream Narrative

I started out 2022 by predicting that capitalism and common sense would catalyze a massive pivot in how the mainstream media reports on Covid.

I believed that the media would eventually start the process of pivoting from hysteria and that politicians, understanding full well that they can’t get re-elected during mid-terms this year on a platform of locking people in their homes, would follow.

All I can say one month into the year is holy shit, does it look like I was right.

So far in 2022, innumerable U.S. states, in addition to countries like Sweden, Norway and Denmark, are lifting Covid restrictions.

Connecticut and Delaware are planning on lifting school mask mandates by the end of March. Oregon officials have also announced that general mask mandates would be lifted March 31. Even New Jersey and California announced they would ease mandates in coming weeks.

And the media narrative has very quickly changed, too.

Dr Leana Wen, columnist with The Washington Post and CNN medical analyst who has, in the past, gushed non-stop about following the government’s Covid guidance, has now completely changed her playbook for her appearances on CNN.

On Monday of this week, she told CNN:

“There was, and is, a time and place for pandemic restrictions. But when they were put in, it was always with the understanding that they would be removed as soon as we can. And, in this case, circumstances have changed. Case counts are declining. Also, the science has changed. The responsibility should shift from a government mandate imposed from the state or the local district of the school … it should shift to an individual responsibility by the family, who can still decide that their child can wear a mask if needed.”

Keep reading

University That Funds Biden’s Think Tank And Hosts FactCheck.Org Has Contract With BioNTech, Gets Paid For Vaccine Sales And FDA Approvals

Documents obtained by NATIONAL FILE show that the University of Pennsylvania, which hosts and funds Joe Biden’s think tank called the Penn Biden Center, directly profits from the sale of Pfizer-BioNTech and Moderna Coronavirus vaccines. The University gets more money if more vaccines are sold. The University of Pennsylvania also gets “milestone payments” when the Food and Drug Administration (FDA) approves a Pfizer-BioNTech vaccine. BioNTech pays the University of Pennsylvania Board of Trustees directly, and the university is protected from civil liability if people try to sue for “bodily injury” or “death” caused by BioNTech vaccines.

BioNTech signed a licensing agreement in 2018 with the University of Pennsylvania, which directly funds the Penn Biden Center for Diplomacy and Global Engagement. Even though Coronavirus had not yet broken out when the deal was made, the 2018 agreement ensured massive payments for the University of Pennsylvania if its technology ended up getting used in new mRNA-based vaccines. Well, UPenn’s technology did end up getting used in the mRNA-based Coronavirus vaccine produced by Pfizer and BioNTech, and the deal has led to massive revenue for the university. Joe Biden, who was working for the University of Pennsylvania when the deal was made, received more than $900,000 from the University of Pennsylvania in the two years before he ran for president in this past election.

The University of Pennsylvania also houses the pro-vaccine website FactCheck.org. University of Pennsylvania president Amy Gutmann is now Biden’s nominee for Ambassador to Germany. The Biden administration’s FDA has speedily approved or authorized Pfizer-BioNTech vaccines including for children — all while the Penn Biden Center’s parent university enjoys massive profits from vaccine sales and FDA approval. And the Pfizer-connected FDA even knew about numerous adverse events for children related to the Pfizer-BioNTech vaccine, but allowed children to be injected with it anyway. Now, as the FDA considers emergency use authorization for a Pfizer-BioNTech vaccine for children as young as six months old, the direct financial relationship between these vaccines and Joe Biden’s think tank must be exposed.

Keep reading

The British Medical Journal Story That Exposed Politicized “Fact-Checking”

In February of 2010, the New York Times released a front page story entitled, “Research Ties Diabetes Drug to Heart Woes.” The lede read:

Hundreds of people taking Avandia, a controversial diabetes medicine, needlessly suffer heart attacks and heart failure each month, according to confidential government reports that recommend the drug be removed from the market.

The Times piece quoted an internal F.D.A. report that said the GlaxoSmithKline diabetes drug Avandia, also known as Rosiglitazone, was “linked” to 304 deaths in 2009, adding the conclusion of the two doctors who authored the report: “Rosiglitazone should be removed from the market.” The story was released in advance of a Senate Finance Committee study that produced a series of damning internal documents, including one in which an FDA safety officer expressed concern that Avandia presented such serious cardiovascular risks that “the safety of the study itself cannot be assured, and is not acceptable.”

One of the chief investigators on that study was Paul Thacker, at the time a committee aide under Iowa Republican Chuck Grassley. Multi-year document hauls like the Avandia report were Thacker’s stock in trade. I first met him around then because his committee frequently dealt with financial crisis issues I covered. Thacker, who went on to contribute to a number of commercial and academic journals, was trained in a tradition of bipartisan committee reporting that relies heavily on documents and on-the-record testimony, i.e. the indisputable stuff both sides are comfortable backing.

Thacker has an in-your-face style and a dark sense of humor, and talking to him can feel like being lost in a Bill Hicks routine, but his information is good. In his years in the Senate, his job was publicizing damaging information about the world’s most litigious companies. Certain Washington jobs require a healthy fear of the $1000-an-hour lawyers that every Fortune 500 company has on speed dial, and Thacker has always retained the Beltway investigator’s usefully paranoid approach to publishing.

“I know how to do these things,” he says. “I know how to work with whistleblowers.”

It was more than a little surprising, then, when Thacker’s name appeared in the middle of a bizarre international fact-checking controversy. In an article for one of the world’s oldest academic outlets, the British Medical Journal, Thacker wrote a piece entitled, “Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial.” He did what he’d done countless times, shepherding into print the tale of an apparent whistleblower with an unsettling story. Brook Jackson worked for a Texas firm called Ventavia that conducted a portion of the research trials for Pfizer’s Covid-19 vaccine. This is the same vaccine that Thacker himself, who now lives in Spain and is married to a physician, had taken.

After going through both legal and peer review, but without contacting Ventavia — apparently, they feared an injunction — the BMJ published Thacker’s piece on November 2nd, 2021. The money passage read:

A regional director who was employed at the research organization Ventavia Research Group has told The BMJ that the company falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in Pfizer’s pivotal phase III trial.

Beginning on November 10th, 2021, the editors began receiving complaints from readers, who said they were having difficulty sharing it. As editors Fiona Godlee and Kamran Abbassi later wrote in an open letter to Facebook CEO Mark Zuckerberg:

Some reported being unable to share it. Many others reported having their posts flagged with a warning about “Missing context … Independent fact-checkers say this information could mislead people.” Those trying to post the article were informed by Facebook that people who repeatedly share “false information” might have their posts moved lower in Facebook’s News Feed. Group administrators where the article was shared received messages from Facebook informing them that such posts were “partly false.”

Facebook has yet to respond to queries about this piece. Meanwhile, the site that conducted Facebook’s “fact check,” Lead Stories, ran a piece dated November 10th whose URL used the term “hoax alert” (Lead Stories denies they called the BMJ piece a hoax). Moreover, they deployed a rhetorical device that such “checking” sites now use with regularity, repeatedly correcting assertions Thacker and the British Medical Journal never made. This began with the title: “The British Medical Journal Did NOT Reveal Disqualifying And Ignored Reports Of Flaws In Pfizer COVID-19 Vaccine Trials.”

The British Medical Journal never said Jackson’s story revealed “disqualifying flaws” in the vaccine. Nor did it claim the negative information “calls into question the results of the Pfizer clinical trial.” It also didn’t claim that the story is “serious enough to discredit data from the clinical trials.” The BMJ’s actual language said Jackson’s story could “raise questions about data integrity and regulatory oversight,” which is true.

The real issue with Thacker’s piece is that it went viral and was retweeted by the wrong people. As Lead Stories noted with marked disapproval, some of those sharers included the likes of Dr. Robert Malone and Robert F. Kennedy. To them, this clearly showed that the article was bad somehow, but the problem was, there was nothing to say the story was untrue.

Keep reading